Amicus Therapeutics, Inc., CEO and Chairman

John Crowley became president and CEO of Amicus in January 2005 and was appointed Chairman of the Board in February 2010. Read more »

Ulrich Grau, Ph.D., was co-founder, President and CEO of Lux Biosciences. Dr. Grau has 25 years of experience in the biotechnology and pharmaceutical industry. Prior to founding Lux Biosciences in 2005, Read more »

Eli Lilly and Company, President, Global Oncology Business Unit and Senior Vice President

John H. Johnson has more than two decades of executive and operational management experience in the biopharmaceutical and healthcare industries. Read more »

Merck & Co., Inc., Senior Vice President, Business Development & Corporate Licensing

Mr. Kender is responsible for Corporate Development, Corporate Licensing, Human Health Business Development, U.S.H.H. Business Development and Financial Evaluation and Analysis. Read more »

Chromocell, CEO

Christian Kopfli, Esq., serves as the CEO of Chromocell. From 1998 to 2003, Christian was an associate at Davis Polk & Wardwell in New York City Read more »

Vicus Therapeutics, President and CEO

John W. Maki serves as President and CEO of Vicus Therapeutics, LLC. He previously served as Managing Director of Technology Directors, Read more »

Unigene Laboratories; Director

Marvin L. Miller has a broad background in senior management of health care enterprises, including biotechnology, pharmaceuticals, in vitro diagnostics, clinical laboratory Read more »

NPS Pharmaceuticals, Inc., President & CEO

Dr. Francois Nader has been President and CEO of NPS since March 2008. Dr. Nader joined NPS in June 2006 and served as executive vice president and chief operating officer Read more »

PTC Therapeutics, Inc., President and CEO

Dr. Peltz founded PTC Therapeutics, Inc. in 1998 and has been the company’s President and CEO leading all activities from research to fund raising. Read more »

Elusys Therapeutics, Inc., President and CEO

Elizabeth Posillico, Ph.D. joined Elusys in 2002 as Vice President of Business Development and since then moved to take on more management responsibilities of the company Read more »

Johnson & Johnson, Worldwide Vice President, Biopharmaceutical Public Policy and Advocacy

Gary Reedy serves as Worldwide Vice President, Biopharmaceutical Public Policy and Advocacy with Johnson & Johnson, the world’s most comprehensive healthcare manufacturer. Read more »

Cyclacel Pharmaceuticals, Inc., President & CEO

Spiro Rombotis, President and Chief Executive Officer of Cyclacel Pharmaceuticals, Inc. (Berkeley Heights, NJ and Dundee, Scotland), joined the company in August 1997 as the founding CEO.  He has over 27 years of experience with pharmaceutical and biotechnology companies.   Read more »

Tobira Therapeutics, Inc., President & CEO

James is CEO and President of Tobira Therapeutics, a Manalapan, NJ- based biopharmaceutical company developing novel compounds for HIV/AIDS and inflammatory diseases. Read more »

Soligenix, Inc., President and CEO

Christopher J. Schaber, Ph.D., has over 20 years experience in both big pharma and start-up biotech. He has been Soligenix’s President Read more »

Phytomedics, Inc., President & CEO

Dr. Laurie Smaldone Alsup joined Phytomedics, Inc. as President and CEO in 2008. Phytomedics of Jamesburg, NJ is focused on the discovery, development, Read more »